Testing effectiveness (Phase 2)Study completedNCT07333352
What this trial is testing
PCV24 Clinical Trial in Infants and Young Children Aged 2 Months (Minimum 6 Weeks) to 71 Months
Who this might be right for
Pneumococcal Infectious Disease
Reinovax Biologics Co., LTD 480